Lilly Trade Secrets Theft Case In China Puts Spotlight On Prevalent Problem

Two former Lilly biologists are indicted in the U.S. for passing early research in cancer, diabetes and metabolic disorders to Hengrui, a Chinese competitor. While few such cases become public, it is a constant worry for industry.